New cell therapy trial aims to tackle frailty in seniors
NCT ID NCT07462819
First seen Mar 11, 2026 · Last updated May 24, 2026 · Updated 14 times
Summary
This early-stage study tests whether Stemis™, made from stem cells, is safe for older adults (ages 60-85) with mild to moderate frailty. About 12 participants will receive either Stemis™ or a placebo by IV. The main goal is to check for side effects, not to treat frailty directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Taipei Medical University Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.